Literature DB >> 10941809

High incidence of parvovirus B19 DNA in synovial tissue of patients with undifferentiated mono- and oligoarthritis.

H D Stahl1, B Seidl, B Hubner, S Altrichter, R Pfeiffer, B Pustowoit, U G Liebert, J Hofmann, G von Salis-Soglio, F Emmrich.   

Abstract

A common problem in rheumatological practice is inflammatory joint disease that cannot be classified. The prognosis of such undifferentiated arthritides is uncertain. The synovial tissue of 41 consecutive patients with various forms of arthritis was tested for the presence of viral DNA in a diagnosis-unaware fashion, using the polymerase chain reaction (PCR). Of all tested viruses, cytomegalovirus and parvovirus B19 were positive (each in 10 patients, two double-positives), whereas herpes simplex virus was positive in two patients. Rubella virus RNA was detected in three specimens. When the positivity for viral material was analysed in terms of distribution among the various diagnostic groups, it became evident that five out of 10 parvovirus B 19-positive patients belonged to the undifferentiated arthritis group, whereas cytomegalovirus-positive patients were spread among all diagnostic groups. This indicates the possibility of a new diagnostic category of undifferentiated mono- and oligoarthritis, which can be identified by the presence of parvovirus B19 DNA in synovial tissue.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10941809     DOI: 10.1007/s100670070046

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

1.  Parovirus B19-associated mono- and oligoarticular arthritis may evolve into a chronic inflammatory arthropathy fulfilling criteria for rheumatoid arthritis or spondylarthropathy.

Authors:  H D Stahl; R Pfeiffer; G Von Salis-Soglio; F Emmrich
Journal:  Clin Rheumatol       Date:  2000       Impact factor: 2.980

2.  [Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative].

Authors:  I H Tarner; K Albrecht; M Fleck; E Gromnica-Ihle; G Keyßer; L Köhler; I Kötter; K Krüger; J Kuipers; H Nüßlein; A Rubbert-Roth; J Wollenhaupt; M Schneider; B Manger; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2014-05       Impact factor: 1.372

Review 3.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  The relationship between arthritis and human parvovirus B19 infection.

Authors:  R Caliskan; S Masatlioglu; M Aslan; S Altun; S Saribas; S Ergin; E Uckan; V Koksal; V Oz; K Altas; I Fresko; B Kocazeybek
Journal:  Rheumatol Int       Date:  2004-08-20       Impact factor: 2.631

5.  Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.

Authors:  P Machado; I Castrejon; W Katchamart; R Koevoets; B Kuriya; M Schoels; L Silva-Fernández; K Thevissen; W Vercoutere; E Villeneuve; D Aletaha; L Carmona; R Landewé; D van der Heijde; J W J Bijlsma; V Bykerk; H Canhão; A I Catrina; P Durez; C J Edwards; M D Mjaavatten; B F Leeb; B Losada; E M Martín-Mola; P Martinez-Osuna; C Montecucco; U Müller-Ladner; M Østergaard; B Sheane; R M Xavier; J Zochling; C Bombardier
Journal:  Ann Rheum Dis       Date:  2010-08-19       Impact factor: 19.103

6.  Human endogenous retrovirus W activity in cartilage of osteoarthritis patients.

Authors:  Signy Bendiksen; Inigo Martinez-Zubiavrra; Conny Tümmler; Gunnar Knutsen; Jan Elvenes; Elisabeth Olsen; Randi Olsen; Ugo Moens
Journal:  Biomed Res Int       Date:  2014-07-22       Impact factor: 3.411

7.  Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia.

Authors:  Helen M Faddy; Elise C Gorman; Veronica C Hoad; Francesca D Frentiu; Sarah Tozer; R L P Flower
Journal:  BMC Infect Dis       Date:  2018-12-07       Impact factor: 3.090

8.  Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis.

Authors:  Benedikt Weissbrich; Yvonne Süss-Fröhlich; Hermann J Girschick
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.